(NASDAQ: IRTC) Irhythm Holdings's forecast annual revenue growth rate of 13.2% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.47%.
Irhythm Holdings's revenue in 2026 is $825,336,000.On average, 17 Wall Street analysts forecast IRTC's revenue for 2026 to be $29,625,498,946, with the lowest IRTC revenue forecast at $28,362,686,301, and the highest IRTC revenue forecast at $30,600,544,575. On average, 17 Wall Street analysts forecast IRTC's revenue for 2027 to be $34,281,523,120, with the lowest IRTC revenue forecast at $32,419,443,081, and the highest IRTC revenue forecast at $36,028,562,279.
In 2028, IRTC is forecast to generate $39,621,529,606 in revenue, with the lowest revenue forecast at $37,083,378,375 and the highest revenue forecast at $42,291,532,849.